@mpndoc

Physician-scientist interrogating inflammatory cytokine-signaling networks in myeloproliferative neoplasms. #mpnsm. Co-Chief @WashUHematology.

 St. Louis, MO
ohlab.org/
Joined December 2014
  • Tweets2.4K
  • Following967
  • Followers3K
648Media
I am thrilled to share that the news that I have been named the Samuel B. Grant Professor of Medicine! 🥳 I am deeply grateful to the extraordinary #OhTeam members, collaborators, mentors, colleagues, & friends whose support have made this journey possible! 🤩 @WashUHematology
WashU Medicine Department of Medicine@WashUDeptMedJul 13
#WashUDeptMed announces Stephen Oh, MD, was named the Samuel B. Grant Professor of Medicine. Dr. Oh is currently Co-Chief @WashUHematology and recognized for advancing the understanding of blood cancers, particularly myeloproliferative neoplasms. Kudos> internalmedicine.wustl.edu/s…
Stephen Oh, MD, was named the Samuel B. Grant Professor of Medicine

ALT Stephen Oh, MD, was named the Samuel B. Grant Professor of Medicine

21
12
1
102
11,011
Stephen T. Oh, MD, PhD, Grant A. Challen, PhD, Daniel C. Link, MD and colleagues have received an NIH grant to study how inflammation drives blood cancers, advancing research that could lead to new therapies for patients with myeloproliferative neoplasms. source.washu.edu/2026/09/11-…

$11.7 million from NIH supports research on inflammation in blood cancers

A grant to WashU Medicine researchers will fund the study of how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia.

source.washu.edu
1
1
143
In a study led by Dr. Stephen Oh, researchers at WashU Medicine have identified a possible route to tame inflammation in myeloproliferative neoplasms — a group of chronic blood cancers — that could serve as a novel approach to treatment. source.washu.edu/2026/10/pro…

Promising target identified against chronic blood cancer

WashU Medicine researchers have identified a promising approach to treatmyeloproliferative neoplasms, a group of chronic blood cancers, by interfering with a protein that drives inflammation.

source.washu.edu
1
2
9
435
Sadly not able to stay and fully experience The Most Magical Place on Earth but big thank you 🙏 @md_padron for inviting me to speak at the inaugural Translational Myeloid Conference chock full of stimulating talks from many leaders in the field! @MoffittNews #disneycaricature
3
1
41
1,424
The NIH has awarded WashU Medicine an $11.7 million grant to study how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia. source.washu.edu/2026/09/11-…

$11.7 million from NIH supports research on inflammation in blood cancers

A grant to WashU Medicine researchers will fund the study of how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia.

source.washu.edu
1
2
16
1,347
Why do some pts with MPNs stay stable for decades while others progress? @MPN_RF launched the MPN Progression Research Network in 2020 to address this pressing issue. We now present a blueprint for dealing with progression from these efforts. (nature.com/articles/s41375-0…).A thread🧵
2
18
2
37
3,084
A study by WashU hematology researchers shows that a novel blood-based digital PCR test can detect when treatment is failing a median of three months before standard of care testing identifies treatment failure. Findings published in Haematologica. hematology.wustl.edu/catchin…
1
2
190
The findings from a study led by WashU hematology’s Yoon-A Kang, PhD, were recently published in Blood Advances. Researchers discovered how unfolded protein response signaling promotes myeloid cell production and cooperates with oncogenic mutation. hematology.wustl.edu/study-r…
1
6
295
What an incredible past few days for our @washumedicine MPN program! 🤩 #mpnsm
2
2
29
846
more replies
And on Saturday, we were honored to be joined by @GabyHobbs & @KuykendallMd for our MPN patient education program. Attended by more than 100 patients & guests, the event provided an opportunity to learn about current and emerging approaches to diagnosis and management of MPNs. 4/
1
1
1
9
1,873
I am so proud of the important and impactful work from our WashU MPN program, and I am excited by the positive momentum for the MPN field more broadly! 🙏 Stay tuned for more exciting news for our WashU MPN program, details to be shared soon! 😃 @WashUDeptMed @SitemanCenter
1
3
182
Promising target identified against chronic blood cancer. The study is led by Stephen Oh, MD, PhD, Co-Director of the Division of Hematology at WashU Medicine. insidemedicine.washu.edu/pro…

Promising target identified against chronic blood cancer - Inside WashU Medicine

WashU Medicine researchers have identified an approach to treat myeloproliferative neoplasms by interfering with a protein that drives inflammation.

insidemedicine.washu.edu
1
2
2
244
WashU Hematology Researchers Publish Findings on Anticoagulant Safety Gaps and Bleeding Risks hematology.wustl.edu/washu-h…
1
1
1
4
441
👉👉👉MPN Workshop of the Carolinas 2026 just completed! ✔️ Co-founded by @mpdrc & @doctorpemm in partnership with @spahec 👏 We had a super successful patient-centered research 💡 meeting for developing & discussing new ideas 💡 for the #MPNSM field! 🙏 to our stellar faculty!
12
2
41
5,891
Thanks so much @doctorpemm & @mpdrc for hosting an outstanding Carolinas MPN Workshop at beautiful Hilton Head Island! 🤩 Grateful for the opportunity to share our work, hear about exciting developments in the field, & enjoy quality time with many #MPNfriends and colleagues!
2
5
36
1,850
👉👉👉Outstanding talk by Dr Ami Patel @AmiBPatelMD on atypical CML at MPN Workshop of the Carolinas ! 🙏 🙏 🙏 👏 👏 👏 #RareDisease #MPNSM | #ASXL1 #SETBP1
2
8
30
1,827
Beautiful talk by @AmiBPatelMD on atypical CML, featuring Molly Patel ❤️🐾 #MPNSM
1
7
21
1,244
👉👉👉Superb talks to kick off day 2 at our MPN Workshop of the Carolinas by Dr Dunbar @JAK2TheFuture & Dr Shannon Elf @TheElfLab , brilliantly setting the stage for our biological understanding as we enter new #JAK2 and #CALR targeted clinical era | @mpdrc #MPNSM
7
1
28
3,844
Load more